"ProteoMediX AG - Product Pipeline Analysis, 2015 Update" is now available at Fast Market Research

Summary

ProteoMediX AG (ProteoMediX) is a diagnostic company. The company identifies and develops biomarkers for the early detection of cancer and the personalized treatment. It offers products for prostate cancer detection, prostate cancer stratification, and prostate cancer prognosis. The company's biomarkers are used for detecting PI3K/PTEN cancer pathway activity to guide therapy selection for cancer patients. ProteoMediX discovers biomarkers using a genetics-guided discovery approach. The company develops multiplexed immunoassay-based blood test that reduces unneeded biopsies by monitoring biomarkers associated with prostate cancer development. ProteoMediX serves patients with prostate and other types of cancer. The company is a spinoff company of ETH Zurich. ProteoMediX is headquartered in Schlieren, Switzerland.In April 2014, the company raised US$3.62m in series B venture financing round from Altos Venture, Zurcher Kantonalbank and other investors. It is raised for the development of lead product, a protein test for the detection of prostate cancer.

Full Report Details at
- http://www.fastmr.com/prod/990267_proteomedix_ag_product.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company ProteoMediX AG
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Acrostak (Schweiz) AG - Product Pipeline Analysis, 2015 Update
- Instrumentation Laboratory Company - Product Pipeline Analysis, 2015 Update
- aap Implantate AG (AAQ) - Product Pipeline Analysis, 2014 Update
- Analyticon Biotechnologies AG - Product Pipeline Analysis, 2014 Update
- Siemens Healthcare - Product Pipeline Analysis, 2015 Update